COVID-19 update: Jan. 21, 2022
Resources for members to share with patients and COVID-19 summary of evidence report updated
Candidate data reporting policy action reinstated due to COVID-19 impact
Effective immediately, OPTN Policy 1.4.F has been reinstated, addressing data submission requirements for transplant candidates in cases where data collection is affected by the COVID-19 outbreak.
COVID-19 update: Jan. 11, 2022
OPTN Policy 1.4.F has been reinstated, which authorizes transplant programs, as needed, to “carry forward” the most recent clinical data available when obtaining updated data is not feasible due to effects of the COVID-19 pandemic.
COVID-19 update: Jan. 6, 2022
Update: FDA to expand use of Pfizer-BioNTech vaccine. Winter 2022 regional meetings and site surveys will be virtual.
COVID-19 update: Dec. 16, 2021
FDA approves antibody-based COVID-19 prophylaxis for immunocompromised people
COVID-19 update: Dec. 2, 2021
Site surveys to gradually transition to in-person visits starting in December